Alexander Y. Tokman - May 16, 2022 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role: Director
Signature: /s/ Alexander Tokman by Mark Busch, attorney-in-fact
Stock symbol: NDRA
Transactions as of: May 16, 2022
Transactions value $: $19,630
Form type: 4
Date filed: 5/17/2022, 04:14 PM
Previous filing: Mar 30, 2022
Next filing: Aug 24, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NDRA	Common Stock	Purchase	$19.6K	+100K	+304.35%	$0.20	133K	May 16, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1911 to $0.1963, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1911 to $0.1963, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.